Cite
HARVARD Citation
Li, C. et al. (2022). Risk‐Based Pharmacokinetic and Drug–Drug Interaction Characterization of Antibody–Drug Conjugates in Oncology Clinical Development: An International Consortium for Innovation and Quality in Pharmaceutical Development Perspective. Clinical pharmacology & therapeutics. 112 (4), pp. 754-769. [Online].